Cover Image

Pretreatment Hepatitis C Virus NS5A/NS5B resistance-associated substitutions in genotype 1 uruguayan infected patients

Hepatitis C Virus (HCV) infection treatment has dramatically changed with the advent of direct-acting antiviral agents (DAAs). However, the efficacy of DAAs can be attenuated by the presence of resistance-associated substitutions (RASs) before and after treatment. Indeed, RASs detected in DAA treatm...

Full description

Saved in:
Main Author: Aldunate Caramori, Fabián (author)
Other Authors: Echeverría Chagas, Natalia (author), Chiodi, Daniela (author), López, Pablo (author), Sánchez Cicerón, Adriana (author), Fajardo Rossi, Álvaro (author), Sóñora, Martín (author), Cristina, Juan (author), Hernández, Nelia (author), Moreno Karlen, María del Pilar (author)
Format: article
Language:English
Published: 2018
Subjects:
Hepacivirus
Hepatitis C
Antivirals DAAs
Online Access:https://hdl.handle.net/20.500.12008/22071
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items: Pretreatment Hepatitis C Virus NS5A/NS5B resistance-associated substitutions in genotype 1 uruguayan infected patients

Similar Items